Aranda-Lara, L.; Isaac-Olivé, K.; Ocampo-GarcÃa, B.; Ferro-Flores, G.; González-Romero, C.; Mercado-López, A.; GarcÃa-MarÃn, R.; Santos-Cuevas, C.; Estrada, J.A.; Morales-Avila, E.
Engineered rHDL Nanoparticles as a Suitable Platform for Theranostic Applications. Molecules 2022, 27, 7046.
https://doi.org/10.3390/molecules27207046
AMA Style
Aranda-Lara L, Isaac-Olivé K, Ocampo-GarcÃa B, Ferro-Flores G, González-Romero C, Mercado-López A, GarcÃa-MarÃn R, Santos-Cuevas C, Estrada JA, Morales-Avila E.
Engineered rHDL Nanoparticles as a Suitable Platform for Theranostic Applications. Molecules. 2022; 27(20):7046.
https://doi.org/10.3390/molecules27207046
Chicago/Turabian Style
Aranda-Lara, Liliana, Keila Isaac-Olivé, Blanca Ocampo-GarcÃa, Guillermina Ferro-Flores, Carlos González-Romero, Alfredo Mercado-López, Rodrigo GarcÃa-MarÃn, Clara Santos-Cuevas, José A. Estrada, and Enrique Morales-Avila.
2022. "Engineered rHDL Nanoparticles as a Suitable Platform for Theranostic Applications" Molecules 27, no. 20: 7046.
https://doi.org/10.3390/molecules27207046
APA Style
Aranda-Lara, L., Isaac-Olivé, K., Ocampo-GarcÃa, B., Ferro-Flores, G., González-Romero, C., Mercado-López, A., GarcÃa-MarÃn, R., Santos-Cuevas, C., Estrada, J. A., & Morales-Avila, E.
(2022). Engineered rHDL Nanoparticles as a Suitable Platform for Theranostic Applications. Molecules, 27(20), 7046.
https://doi.org/10.3390/molecules27207046
